Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salsalate for Microvascular Dysfunction After Preeclampsia
NCT03482440Phase 1Completed
- Sponsor
- University of Iowa
- Start
- Aug 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in preeclampsia comparing Salsalate with Placebo (2 arms). Primary endpoint: Microvascular Endothelial Function (Cutaneous Conductance, %Maximum) at 4 days. Started Aug 2018; status: completed.
02
Drugs
Amigesic
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT03482440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03482440.